deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT04101877

The Sahlgrenska Anti-VEGF Study (SAHLVE)

The Sahlgrenska Anti-VEGF (SAHLVE) Study - a Prospective Randomized Double-blind Comparison of Bevacizumab and Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Sponsor: Vastra Gotaland Region

Conditions Neovascular Age-related Macular Degeneration
Interventions Aflibercept Injection Bevacizumab Injection
Updated 11 times since 2019 Last updated: Nov 17, 2025 Started: Sep 3, 2020 Primary completion: Oct 31, 2026 Completion: May 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Neovascular Age-related Macular Degeneration, this trial is ongoing. The trial is conducted by Vastra Gotaland Region and has accumulated 11 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshotNot Yet Recruiting~Nov 2019 – ~Jul 2020 · 8 months · monthly snapshotNot Yet Recruiting~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2021 – ~May 2022 · 15 months · monthly snapshotRecruiting~May 2022 – ~Jul 2023 · 14 months · monthly snapshotRecruiting~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotRecruiting~Jul 2025 – ~Dec 2025 · 5 months · monthly snapshotUnknown~Dec 2025 – present · 7 months · monthly snapshotActive Not Recruiting

Change History

11 versions recorded

  1. Dec 2025 — Present [monthly]

    Active Not Recruiting PHASE2

    Status: Unknown → Active Not Recruiting

  2. Jul 2025 — Dec 2025 [monthly]

    Unknown PHASE2

    Status: Recruiting → Unknown

  3. Sep 2024 — Jul 2025 [monthly]

    Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Jul 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

▶ Show 6 earlier versions

  1. May 2022 — Jul 2023 [monthly]

    Recruiting PHASE2

  2. Feb 2021 — May 2022 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  3. Jan 2021 — Feb 2021 [monthly]

    Not Yet Recruiting PHASE2

  4. Jul 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

  5. Nov 2019 — Jul 2020 [monthly]

    Not Yet Recruiting PHASE2

  6. Oct 2019 — Nov 2019 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Vastra Gotaland Region
Data source: Vastra Gotaland Region

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations